APA (7th ed.) Citation

(2022). Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia.

Chicago Style (17th ed.) Citation

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia. 2022.

MLA (8th ed.) Citation

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia. 2022.

Warning: These citations may not always be 100% accurate.